Company Filing History:
Years Active: 1989
Title: Koichi Shimohara: Innovator in Anti-Ulcer Compounds
Introduction
Koichi Shimohara is a notable inventor based in Neyagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. His work focuses on innovative compounds that have the potential to improve health outcomes for patients suffering from peptic ulcers.
Latest Patents
Shimohara holds a patent for "Piperazine compounds and anti-ulcer composition containing the same." This patent describes novel piperazine compounds characterized by a specific formula, where either one of R¹ and R² is a methoxy group and the other is a hydrogen atom, or a pharmaceutically acceptable acid addition salt thereof. These compounds exhibit excellent anti-peptic ulcer activities and are effective in promoting the action of the defensive factor, making them useful as anti-ulcer agents for both prophylaxis and treatment of peptic ulcers. He has 1 patent to his name.
Career Highlights
Koichi Shimohara is associated with Kanebo, Limited, where he has been instrumental in advancing research and development in pharmaceutical innovations. His expertise in piperazine compounds has positioned him as a key figure in the industry.
Collaborations
Throughout his career, Shimohara has collaborated with esteemed colleagues, including Hiroshi Ohtaka and Kenji Yoshida. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Koichi Shimohara's contributions to the field of anti-ulcer compounds highlight his role as an influential inventor. His work not only advances pharmaceutical science but also offers hope for improved treatments for peptic ulcer patients.